Madrigal Pharmaceuticals’ resmetirom is a leading treatment candidate for the advanced form of fatty liver disease.
You are here: Home / Top Stories / : Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval